Post by
BetulaKapital on Dec 02, 2022 11:47am
Nova Leap Health - New corporate presentation on the website
Nova Leap Health - New corporate presentation on the company's website
Free here: https://novaleaphealth.com/corporate-presentation/
Some highlights:
Market Leader in an Essential and Growing Industry
• Performing a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care
• Growth opportunities driven by an aging demographic and a constant pipeline of opportunities in a highly fragmented industry
Impressive History of Rapid Growth and Well-Positioned to Capitalize on a Fragmented Industry
• 19 acquisitions completed since 2016 at an average target revenue multiple of 0.5x and target EBITDA multiples in the range of 3.0-5.0
• >90% of companies active in the sector are mom and pop shops with the top three players comprising <5% of home care sector revenue
• Substantial organic and acquisition growth opportunities
• Operations in 11 different States as well as Nova Scotia, Canada
Strong Financial Performance and Position
• Reported record year to date revenues and record quarterly adjusted EBITDA in Q3 2022
• Increasing gross margins demonstrate ongoing pricing power in an inflationary environment
• As of the end of Q3, available cash of USD$2.2M and full access to revolving credit facility of CAD$1.5M
• By end of 2023, outstanding balance on existing demand loans projected to be USD$265K
Aligned Management Team with History of Execution
• Management has repeatedly demonstrated ability to identify, negotiate and close on acquisitions favorable to shareholders
• Insider ownership of 38.8% creates alignment with external shareholders
Attractive Investment Opportunity
• Improved financial performance and opportunity for growth creates attractive investment opportunity at current share price
• Analyst coverage at an average buy rating of $0.95
And perhaps the most reassuring thing, despite being acquisition-free in 2022, the goals for 2026 are intact:
Target Metrics
• Nova Leap has achieved annualized revenues and adjusted EBITDA of US$28.3 million and USD$1.3 million based on Q3 2022 results;
• By the end of 2026, targeting a minimum of US$100 million in annualized revenues combined with consolidated annualized Adjusted
EBITDA of at least US$10 million.